Crossmark

Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer

Crossref DOI link: https://doi.org/10.1186/s13058-018-1007-x

Published Online: 2018-08-07

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liang, Xu

Vacher, Sophie

Boulai, Anais

Bernard, Virginie

Baulande, Sylvain

Bohec, Mylene

Bièche, Ivan

Lerebours, Florence

Callens, Céline https://orcid.org/0000-0003-3377-4937
License Information

Text and Data Mining valid from 2018-08-07
More Information

Article History

Received: 20 February 2018

Accepted: 18 June 2018

First Online: 7 August 2018

Ethics approval and consent to participate

: This study was approved by the Curie Institute/Rene Huguenin Hospital ethics committee. Participating patients completed an informed consent process.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.